CD14 and myeloid sarcoma: Silke Walter and cols (2006) described the role of CD14 (LPS receptor) in EAE for the first time, in agreement with the findings of the increased immunoreactivity of CD14 in biopsy and postmortem brain tissues of MS patients when compared to age-matched controls.